Page 452 - Traité de chimie thérapeutique 6 Médicaments antitumoraux

408 MÉDICAMENTS INDUISANTOUSTABILISANT DES COUPURES DE L'ADN

TEWEY K.M. et al., Intercalative antitumor drugs interfere with the breakage-reunion
reaction of mammalian DNA topoisomerase 11, J. Biol. Chem., 1984, 259, 91829187.
TEWEY K.M. et al., Adriamycin-induced DNA damage mediated by mammalian topoiso-
merase 11, Science, 1984, 226, 466-468.
CHEN K.X. et al., A theoretical investigation on the sequence selective binding of dau-
nomycin to double-stranded polynucleotides, J. Biomol. Struct. Dyn., 1985, 3, 445-
466.
GIANNI L. et al., Characterization of the cycle of iron-mediated electron transfer from
adriamycin to molecular oxygen. J. Biol. Chem., 1985, 260, 68206826.
CHAIRES J.B. et al., Site and sequence specificity of the daunomycin-DNA interaction,
Biochemistry, 1987, 26, 8227-8236.
WANG A.H.J. et al., Interactions between an anthracycline antibiotic and DNA : molecu-
lar structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2 A resolution, Bio-
chemistry, 1987, 26, 1152-1163.
COLOMBO R. et al., Dose-dependence of doxorubicin effect on actin assembly in vitro.
Exp. Mol. Pathol., 1988, 49, 297-304.
KONOPA J., G, block induced by DNA crosslinking agents and its possible consequen-
ces. Biochem. Pharmacol., 1988, 37, 23032309.
VICHI P., TRITTON T.R., Stimulation of growth in human and murine cells by adriamycin,
Cancer Res., 1989, 49, 2679-2682.
CHAIRES J.B. et al., Preferential binding of daunomycin to 5'ATCG and 5'ATGC sequen-
ces revealed by footprinting titration experiments, Biochemistry, 1990, 29, 6145-6153.
ITO H. et al., Doxorubicin selectively inhibits muscle gene expression in cardiac muscle
cells in vivo and in vitro, Proc. Natl. Acad. Sci. Etats-Unis, 1990, 87, 42754279.
KROHN K., Synthesis of anthracyclines by electrophilic and nucleophilic addition to
anthraquinones, Tetrahedron, 1990, 22, 291-318.
MOLINARI A. et al., Interaction of anthracyclinic antibiotics with cytoskeletal compo-
nents of cultured carcinoma cells (CG5). Exp. Mol. Pathol., 1990, 53, 11-33.
WASSERMANN K. et al., Effects of morpholinyl doxorubicins, doxorubicin and actinomy-
cin Don mammalian DNA topoisomerases I and 11, Mol. Pharmacol., 1990, 38, 38-45.
WANG A.H.J. et al., Formaldehyde cross-links daunorubicin and DNA efficiently: HPLC
and X-ray diffraction studies, Biochemistry, 1991, 30, 3812-3815.
BACHUR N.R. et al., Helicase inhibition by anthracycline anticancer agents. Mol. Phar-
mac0l. 1992, 41, 993998.
FOGLESON D. et al., Doxorubicin inhibits human DNA topoisomerase, Cancer Chem.
Pharmacol., 1992, 30, 123-125.
GAUDIANO, G. et al., Reduction of daunomycin and 11-deoxydaunomycin with sodium
dithionite in DMSO. Formation of quinone methide sulfite adducts and the first NMR
characterization of an anthracycline quinone methide, J. Am. Chem. Soc., 1992, 114,
5546-5553.
CULLINANE C. et al., Thermal stability of DNA adducts induced by cyanomorpholino-
adriamycin in vitro, Nucleic Acids Res., 1993, 21, 1857-1862.
DINNEN R.D. et al., An anticancer drug-sensitive murine erythroleukemia clone : Impli-
cations for the mechanism of action of antineoplastic drugs, Cancer Res., 1993, 53,
1877-1882.